Tokyo Seimitsu (7729) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Jun, 2025Executive summary
FY2025/3 sales reached ¥150.5B and net profit ¥25.6B, both record highs, driven by strong HPC/Gen.AI and SPE demand.
Orders increased 20% YoY to ¥145.6B, with company-wide growth and stable Metrology segment upgrades.
Operating profit rose 17% YoY to ¥29.7B, recurring profit up 13% to ¥29.9B.
Annual dividend set at ¥253/share, up ¥61 YoY, with a payout ratio of 40.1%.
Mid-term plan (FY2026/3–FY2028/3) targets sales of ¥185.0B, OP of ¥45.0B, and ROE of 15%.
Financial highlights
FY2025/3 sales: ¥150.5B (+12% YoY); operating profit: ¥29.7B (+17% YoY, OPM 20%); net profit: ¥25.6B (+32% YoY).
Gross profit: ¥62.5B, up from ¥54.8B YoY; operating margin improved to 19.7%.
Free cash flow turned positive for the first time in three years, supported by higher profits and asset sales.
Cash and cash equivalents at year-end were ¥54.5B, up from ¥36.7B.
Dividend per share for FY2025/3 totaled ¥253.
Outlook and guidance
FY2026/3 forecast: sales ¥159.0B (+6% YoY), operating profit ¥31.0B (+4% YoY), net profit ¥21.7B (-15% YoY).
Growth expected to continue, led by HPC/SPE demand; Metrology segment to see stable sales with some recovery in testing systems in 2H.
Dividend for FY2026/3 is projected at ¥214/share.
Capex includes land acquisition for a new plant in Hachioji, Tokyo.
Forex assumption: ¥140/USD; minimal forex impact due to high yen-based sales.
Latest events from Tokyo Seimitsu
- Record sales and profit growth driven by HPC and aerospace/defense; outlook raised despite one-time losses.7729
Q3 20266 Feb 2026 - Record 1H sales and strong SPE orders offset by lower net profit from extraordinary loss.7729
Q2 20264 Nov 2025 - Operating profit rose 12% YoY in 1Q FY2026/3, led by strong HPC-related SPE demand.7729
Q1 20264 Aug 2025 - Sales and profit rose year-over-year, outlook and dividend raised, uncertainty remains.7729
Q1 202513 Jun 2025 - Strong 1H results and upward guidance driven by SPE and asset sales, with robust AI and China demand.7729
Q2 202513 Jun 2025 - SPE demand and strong financials drove upward revisions to full-year guidance.7729
Q3 20255 Jun 2025